• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

2,4-Dichloro-pyrido[4,3-d]pyrimidine: A Comprehensive Overview

The compound 2,4-Dichloro-pyrido[4,3-d]pyrimidine, identified by the CAS number 1215074-43-3, is a heterocyclic aromatic compound with significant potential in various fields of chemistry and pharmacology. This molecule belongs to the class of pyridopyrimidines, which are known for their unique structural properties and diverse applications. The structure of 2,4-Dichloro-pyrido[4,3-d]pyrimidine consists of a pyrido[4,3-d]pyrimidine core with two chlorine substituents at the 2 and 4 positions. This substitution pattern imparts specific electronic and steric properties to the molecule, making it a subject of interest in both academic and industrial research.

Recent studies have highlighted the importance of pyridopyrimidines as potential candidates for drug development. The pyrido[4,3-d]pyrimidine scaffold has been shown to exhibit promising activity in various biological systems. For instance, researchers have explored its role as a kinase inhibitor, which is a critical area in cancer therapy. The substitution of chlorine atoms at the 2 and 4 positions further enhances the molecule's ability to interact with biological targets, making it a valuable compound for medicinal chemists.

The synthesis of 2,4-Dichloro-pyrido[4,3-d]pyrimidine involves a multi-step process that typically begins with the preparation of intermediate compounds. One common approach is the condensation reaction between a suitable pyridine derivative and a carbonyl compound under specific reaction conditions. The introduction of chlorine substituents is achieved through electrophilic substitution reactions or other halogenation techniques. The optimization of these synthetic routes has been a focus of recent research efforts to improve yield and purity.

In terms of physical properties, 2,4-Dichloro-pyrido[4,3-d]pyrimidine is characterized by its high melting point and stability under various conditions. These properties make it suitable for use in high-temperature applications or as a precursor for more complex molecules. Additionally, its solubility in organic solvents facilitates its use in organic reactions and analytical techniques such as chromatography and spectroscopy.

The pharmacological evaluation of this compound has revealed interesting findings. In vitro studies have demonstrated its ability to inhibit certain enzymes involved in cellular signaling pathways. This activity suggests potential applications in the treatment of diseases such as cancer or inflammatory disorders. Furthermore, computational modeling has been employed to predict the binding affinity of this compound to various protein targets, providing insights into its mechanism of action.

One area where 2,4-Dichloro-pyrido[4,3-d]pyrimidine has shown particular promise is in the field of medicinal chemistry. Its structure serves as a template for designing more potent and selective drug candidates. By modifying the substituents on the pyridopyrimidine core or introducing additional functional groups, researchers can tailor the molecule's properties to meet specific therapeutic needs.

In conclusion, 2,4-Dichloro-pyrido[4,3-d]pyrimidine (CAS No.: 1215074-43-3) is a versatile compound with significant potential in drug discovery and chemical synthesis. Its unique structure and functional groups make it an attractive target for further research. As advancements in synthetic methods and biological screening continue to evolve, this compound is expected to play an increasingly important role in both academic and industrial settings.

• 20028-68-6(2,4,6-Trichloroquinazoline)
• 6625-94-1(2,4,7-Trichloroquinazoline)
• 171178-48-6(4,6-dichloropyrido[3,4-d]pyrimidine)
• 62484-29-1(2,4,8-Trichloroquinazoline)
• 89583-92-6(Pyrido[4,3-d]pyrimidine,4-chloro-)
• 607-68-1(2,4-Dichloroquinazoline)
• 908240-50-6(2,4-dichloropyrido3,4-dpyrimidine)
• 126728-20-9(2,4-Dichloropyrido[2,3-d]pyrimidine)
• 938443-20-0(2,4,7-Trichloropyrido[2,3-d]pyrimidine)
• 134517-55-8(2,4,5-Trichloroquinazoline)